News

As previously disclosed, PALOMA-1 achieved its primary endpoint with the combination of palbociclib and letrozole significantly prolonging progression-free survival (PFS) compared with letrozole alone in post-menopausal women with

Unlike traditional drug delivery platforms, Microchips Biotech’s implant is capable of responding to wireless signals, which can activate, deactivate or modify the frequency or dose of the drug,

The Vero cell platform is an advanced, cell-based technology for vaccines production. The agreement with Nanotherapeutics includes all assets related to the platform, including vaccines for H5N1, H1N1

The trial will be conducted with ADXS11-001 alone or in combination with MedImmune’s investigational anti-PD-L1 immune checkpoint inhibitor, MEDI4736 The combination drug is indicated to treat advanced, recurrent

The deal will see the two parties establish a global strategic collaboration to jointly develop next generation immunotherapies to treat cancer and auto-immune diseases. NantWorks, through a subsidiary,

NEOD001 targets the circulating soluble amyloid and deposited insoluble amyloid that accumulates in both the AL and AA forms of amyloidosis. According to the company, this is the

The new regulatory submission follows the Japanese approval of dolutegravir as Tivicay tablets 50mg in March 2014. In the approved regions, the single-pill dolutegravir-based regimen is called as

The drug is used for growth deficiency in adults and children as well as for growth failure in babies born small who fail to catch up growth by

The Phase III LUX-Breast 1 trial compared afatinib plus vinorelbine (experimental arm) with trastuzumab plus vinorelbine in patients with HER2-positive metastatic breast cancer after failure of prior trastuzumab-based